These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11536357)

  • 1. Computer modeling and molecular dynamics simulations of ligand bound complexes of bovine angiogenin: dinucleotide topology at the active site of RNase a family proteins.
    Madhusudhan MS; Sanjeev BS; Vishveshwara S
    Proteins; 2001 Oct; 45(1):30-9. PubMed ID: 11536357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computer modeling of human angiogenin-dinucleotide substrate interaction.
    Madhusudhan MS; Vishveshwara S
    Proteins; 2001 Jan; 42(1):125-35. PubMed ID: 11093266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of the native and the ligand-bound structures of eosinophil cationic protein: network of hydrogen bonds at the catalytic site.
    Sanjeev BS; Vishveshwara S
    J Biomol Struct Dyn; 2005 Jun; 22(6):657-72. PubMed ID: 15842171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling of angiogenin - 3-NMP complex.
    Madhusudhan MS; Vishveshwara S
    J Biomol Struct Dyn; 1998 Dec; 16(3):715-22. PubMed ID: 10052627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A molecular dynamics study based post facto free energy analysis of the binding of bovine angiogenin with UMP and CMP ligands.
    Madhusudhan MS; Vishveshwara S; Das A; Kalra P; Jayaram B
    Indian J Biochem Biophys; 2001; 38(1-2):27-33. PubMed ID: 11563327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the dynamics of bovine and human angiogenin: a molecular dynamics study.
    Madhusudhan MS; Vishveshwara S
    Biopolymers; 1999 Feb; 49(2):131-44. PubMed ID: 10070263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-resolution crystal structures of ribonuclease A complexed with adenylic and uridylic nucleotide inhibitors. Implications for structure-based design of ribonucleolytic inhibitors.
    Leonidas DD; Chavali GB; Oikonomakos NG; Chrysina ED; Kosmopoulou MN; Vlassi M; Frankling C; Acharya KR
    Protein Sci; 2003 Nov; 12(11):2559-74. PubMed ID: 14573867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis of substrate specificity in porcine RNase 4.
    Liang S; Acharya KR
    FEBS J; 2016 Mar; 283(5):912-28. PubMed ID: 26748441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward rational design of ribonuclease inhibitors: high-resolution crystal structure of a ribonuclease A complex with a potent 3',5'-pyrophosphate-linked dinucleotide inhibitor.
    Leonidas DD; Shapiro R; Irons LI; Russo N; Acharya KR
    Biochemistry; 1999 Aug; 38(32):10287-97. PubMed ID: 10441122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structures of ribonuclease A complexes with 5'-diphosphoadenosine 3'-phosphate and 5'-diphosphoadenosine 2'-phosphate at 1.7 A resolution.
    Leonidas DD; Shapiro R; Irons LI; Russo N; Acharya KR
    Biochemistry; 1997 May; 36(18):5578-88. PubMed ID: 9154942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtle functional collective motions in pancreatic-like ribonucleases: from ribonuclease A to angiogenin.
    Merlino A; Vitagliano L; Ceruso MA; Mazzarella L
    Proteins; 2003 Oct; 53(1):101-10. PubMed ID: 12945053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of substrate UpA binding to RNase A--computer modelling and energetics approach.
    Seshadri K; Rao VS; Vishveshwara S
    J Biomol Struct Dyn; 1994 Dec; 12(3):581-603. PubMed ID: 7727060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combined kinetic and modeling study of the catalytic center subsites of human angiogenin.
    Russo N; Acharya KR; Vallee BL; Shapiro R
    Proc Natl Acad Sci U S A; 1996 Jan; 93(2):804-8. PubMed ID: 8570639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of substrate uridyl 3',5'-adenosine with ribonuclease A: a molecular dynamics study.
    Seshadri K; Rao VS; Vishveshwara S
    Biophys J; 1995 Dec; 69(6):2185-94. PubMed ID: 8599627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping the ribonucleolytic active site of eosinophil-derived neurotoxin (EDN). High resolution crystal structures of EDN complexes with adenylic nucleotide inhibitors.
    Leonidas DD; Boix E; Prill R; Suzuki M; Turton R; Minson K; Swaminathan GJ; Youle RJ; Acharya KR
    J Biol Chem; 2001 May; 276(18):15009-17. PubMed ID: 11154698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the interactions of human ribonuclease inhibitor with angiogenin and ribonuclease A by mutagenesis: importance of inhibitor residues inside versus outside the C-terminal "hot spot".
    Shapiro R; Ruiz-Gutierrez M; Chen CZ
    J Mol Biol; 2000 Sep; 302(2):497-519. PubMed ID: 10970748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refined crystal structures of native human angiogenin and two active site variants: implications for the unique functional properties of an enzyme involved in neovascularisation during tumour growth.
    Leonidas DD; Shapiro R; Allen SC; Subbarao GV; Veluraja K; Acharya KR
    J Mol Biol; 1999 Jan; 285(3):1209-33. PubMed ID: 9918722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Structures and functions of ribonucleases].
    Irie M
    Yakugaku Zasshi; 1997 Sep; 117(9):561-82. PubMed ID: 9357326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structures of RNase A complexed with 3'-CMP and d(CpA): active site conformation and conserved water molecules.
    Zegers I; Maes D; Dao-Thi MH; Poortmans F; Palmer R; Wyns L
    Protein Sci; 1994 Dec; 3(12):2322-39. PubMed ID: 7756988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular recognition of human eosinophil-derived neurotoxin (RNase 2) by placental ribonuclease inhibitor.
    Iyer S; Holloway DE; Kumar K; Shapiro R; Acharya KR
    J Mol Biol; 2005 Apr; 347(3):637-55. PubMed ID: 15755456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.